secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001651308-24-000154
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeiGene plans to change name to BeOne Medicines Ltd.; ticker to become ONC
--------------------------------------------------------------------------

- Name change to BeOne Medicines Ltd. subject to shareholder approval at a future meeting.
- Nasdaq ticker symbol will change to 'ONC' upon completion of the name change.
- Rebranding reflects commitment to develop innovative cancer medicines through global partnerships.
- Shareholders urged to read definitive proxy statement when filed with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130824000154/0001651308-24-000154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130824000154/bgne-20241114.htm
  HTML page:      https://secwatch.observer/filing/0001651308-24-000154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer